Literature DB >> 2307848

The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes.

M S Paul1, M Aegerter, K Cepek, M D Miller, J H Weis.   

Abstract

The murine CR genes Crry (previously termed mCRY) and Crry-ps (previously termed mCRX) are two distinct, but related, sequences which are the evolutionary homologs to sequences contained within the human CR1 gene. Screening a BALB/c genomic DNA library with the Crry/Crry-ps specific cDNA resulted in the isolation of two clusters of genomic sequences: those specific for Crry and those specific for Crry-ps. The coding sequences of the Crry gene encompass over 25 kb of DNA, whereas the Crry-ps sequences are included within a single 5.6-kb Eco-R1 fragment. The Crry gene consists of 10 separate exons. The first of these contains both the signal sequence and an alternatively spliced 129 bp present in approximately 10% of the Crry transcripts. Of the remaining exons, two encode a single sixty amino acid repeat domain each (A and E), two encode a split sixty amino acid repeat (B), and another encodes two 60 amino acid domains (C and D) fused as one exon. The transmembrane and cytoplasmic regions are both split into two exons each. RNA protection analysis indicates that although there is alternative splicing in the 5' region of the gene, the 3' exons encoding the terminal 60 amino acid repeat, the transmembrane region and cytoplasmic exons are used in the same order in all Crry transcripts. This suggests that the Crry gene product is not found as a secreted protein, but only as a cell surface bound protein. DNA sequence analysis of the Crry-ps gene indicates that this sequence most likely represents a pseudogene resulting from a processed mRNA transcript from the Crry gene. This conclusion is based on the lack of intervening sequences in the Crry-ps gene and the observation that the Crry-ps gene sequence contains both an 11-bp deletion within the "coding" region and a degenerate poly A tail at the 3' end of the homologous sequence. Additionally, RNA protection analysis indicates that mRNA cannot be detected which matches the Crry-ps sequence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307848

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice.

Authors:  Fengming Liu; Lin Wu; Gongxiong Wu; Chun Wang; Lining Zhang; Stephen Tomlinson; Xuebin Qin
Journal:  Atherosclerosis       Date:  2014-03-15       Impact factor: 5.162

2.  Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells.

Authors:  A Tsujimura; K Shida; M Kitamura; M Nomura; J Takeda; H Tanaka; M Matsumoto; K Matsumiya; A Okuyama; Y Nishimune; M Okabe; T Seya
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

3.  Structure of the human aggrecan gene: exon-intron organization and association with the protein domains.

Authors:  W B Valhmu; G D Palmer; P A Rivers; S Ebara; J F Cheng; S Fischer; A Ratcliffe
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

4.  An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.

Authors:  Svetlana N Tchepeleva; Joshua M Thurman; Katherine Ruff; Stephen J Perkins; Laurence Morel; Susan A Boackle
Journal:  J Immunol       Date:  2010-07-21       Impact factor: 5.422

5.  Genetic mapping near the myd locus on mouse chromosome 8.

Authors:  K A Mills; K D Mathews; T Scherpbier-Heddema; R L Schelper; R Schmalzel; H L Bailey; J H Nadeau; K H Buetow; J C Murray
Journal:  Mamm Genome       Date:  1995-04       Impact factor: 2.957

6.  Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry.

Authors:  Takashi Miwa; Lin Zhou; Yuko Kimura; David Kim; Avinash Bhandoola; Wen-Chao Song
Journal:  Blood       Date:  2009-01-09       Impact factor: 22.113

Review 7.  Comparative functional evolution of human and mouse CR1 and CR2.

Authors:  Amanda C Jacobson; John H Weis
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

8.  Murine complement receptor gene expression: Cr2 gene transcripts are depressed during a high dose microbial challenge.

Authors:  S S Tan; E M O'Toole; C B Kurtz; J H Weis
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

Review 9.  Transcriptional control of complement receptor gene expression.

Authors:  Brian K Martin
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

10.  Alternative Complement Pathway Activation Provokes a Hypercoagulable State with Diminished Fibrinolysis.

Authors:  Jason M Samuels; Julia R Coleman; Ernest E Moore; Matt Bartley; Navin Vigneshwar; Mitchell Cohen; Christopher C Silliman; Angela Sauaia; Anirban Banerjee
Journal:  Shock       Date:  2020-05       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.